NCT01414881View on ClinicalTrials.gov

Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

mipomersen

mipomersen 200mg subcutaneously (SC) once weekly

DRUG

Placebo

Placebo administered subcutaneously (SC) once weekly

Trial Locations (1)

Unknown

Columbia-Presbyterian Medical Center, MS Care Center, New York

Sponsors
All Listed Sponsors
collaborator

Ionis Pharmaceuticals, Inc.

INDUSTRY

lead

Kastle Therapeutics, LLC

INDUSTRY